Coronary artery bypass graft surgery. Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group will receive an intervention designed according to a person-centered care approach based on evidence-based practice and clinical
(2) Then, in the intervention group, the educational content related to the designed care program will be sent b
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients: Age over 18 years Performing coronary artery bypass graft (CABG) surgery for the first time in patients No concomitant surgery during CABG surgery Absence of respiratory diseases Absence of drug and alcohol addiction No history of seizures or mental health problems No disturbance of consciousness or cognitive problems Living with a family caregiver (spouse or children) Have adequate health literacy Having a smartphone Ability to use WhatsApp Conscious consent to participate in the study Inclusion criteria for family caregivers: Age over 18 years A close family member of the patient Lack of a history of any mental health problems Living with the patient Have adequate health literacy Having a smartphone Ability to use WhatsApp Ability to communicate effectively The first experience of caring for a patient undergoing CABG surgery Conscious consent to participate in the study
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients: Patient dissatisfaction to continue working with the researcher Re-hospitalization of the patient during the research Patient death during the intervention Exclusion criteria for family caregivers: Dissatisfaction to continue working with the researcher Patient death during the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self- efficacy. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Cardiac Self-Efficacy Scale.;Quality of life. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: MacNew Heart Disease HRQL questionnaire.;Cardiac symptoms. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Cardiac Symptom Scale.;Medication adherance. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Morisky Medication Adherence Scale.;Caregiving burden. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Caregiver Burden Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Mardani
Iran University of Medical Sciences
Outcome results
None listed